Mergers & Acquisitions News 15 October 2025

Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Rani Therapeutics (RANI) Stock Nearly Triples on $1B Chugai Deal – What Investors Should Know

Key Facts – October 18, 2025 RANI Stock Price Explodes on Deal News Rani Therapeutics’ stock price erupted on Friday, Oct. 17, 2025, after the company unveiled its game-changing pharma partnership and a significant financing boost. In pre-market trading, RANI

18 October 2025

BBVA Stock Jumps on Failed Takeover Bid – What’s Next for the Banking Giant?

BBVA Stock Soars on Failed Sabadell Takeover Bid – Analysts See Upside Ahead

BBVA Shares Jump as Takeover Bid Collapses Madrid, October 17, 2025 – Banco Bilbao Vizcaya Argentaria (BBVA) stock jumped sharply on Friday after the Spanish banking giant’s hostile bid for Banco Sabadell fell through. BBVA shares rose about 5–7% in

17 October 2025

Banking · Financial News · Investment Analysis · Mergers & Acquisitions · NYSE:BBVA · NYSE:SAB · Stock Market

GitLab Stock Rockets 11% on Datadog Buyout Buzz – AI Moves and Analyst Reactions

GitLab Shares Surge on Takeover Speculation GitLab Inc.’s stock skyrocketed on October 16 following fresh buyout rumors. Shares jumped 10.6% intraday – from the mid-$40s to a $48.27 close – after a report that cloud-monitoring firm Datadog (DDOG) may be

17 October 2025

Analyst Opinions · Artificial Intelligence · Mergers & Acquisitions · NASDAQ:GTLB · Stock Market · Technology News

GitLab Stock Soars 11% on Datadog Takeover Rumors Amid AI DevOps Boom

GitLab Shares Surge on Takeover Speculation GitLab Inc. (NASDAQ: GTLB) rocketed higher on Thursday amid renewed buyout speculation. The stock surged 10.6% intraday – rising from the mid-$40s to close at $48.27 – after a report that cloud-monitoring firm Datadog

17 October 2025

Artificial Intelligence · DevOps · Mergers & Acquisitions · NASDAQ:GTLB · Stock Market · Tech News

CSX CEO Abruptly Departs Amid Rail Merger Frenzy – What’s Next?

CSX Delivers Earnings Surprise: Stock Jumps as New CEO Navigates Rail Merger Frenzy

Earnings Beat Lifts CSX Stock CSX Corporation (NASDAQ: CSX) delivered stronger-than-expected third quarter results, boosting its stock price in recent trading. Shares of the Jacksonville-based freight railroad rose about 2–3% in after-hours trading following the earnings announcement reuters.com. CSX reported

17 October 2025

Earnings · Leadership · Mergers & Acquisitions · NASDAQ:CSX · NYSE:NSC · NYSE:UNP · Rail Industry · Stocks

BBVA Stock Jumps on Failed Takeover Bid – What’s Next for the Banking Giant?

BBVA Stock on the Rise – Recent Performance BBVA’s stock has been on a volatile upswing, with investors closely tracking every development. As of October 16, BBVA shares trade around €15.72 on the Spanish exchange, roughly 0.4% lower on the

16 October 2025

Banking · Financial News · Investment Analysis · Mergers & Acquisitions · NYSE:BBVA · Stock Market

Capital One Savers Cheated Out of Billions – $425M Settlement Payout Deadline Fast Approaching

Capital One Stock Plunges 6% Amid Settlement Showdown, Big Merger & Earnings Countdown

COF Stock Price – Volatile October Swing Capital One’s stock has see-sawed in mid-October. It closed at $202.42 on Oct. 16, down 5.9% for the day stockanalysis.com, after a sharp afternoon sell-off. This reversal erased a short rally earlier in

16 October 2025

Banking · Earnings Reports · Financial News · Mergers & Acquisitions · NYSE:COF · NYSE:DFS · Stock Market

Omeros Stock Explodes 146% on Surprise $2.1B Novo Nordisk Deal – What Comes Next?

Biotech Bombshell: Omeros Stock Skyrockets on $2.1B Novo Nordisk Deal – What’s Next?

Stock Performance: Recent Surge and Volatility Omeros shares were trading around $4–$4.60 through early October, then exploded on Oct. 15. Data from the company’s IR site show OMER jumped from $4.10 (Oct 14 close) to $10.42 by Oct 15 close

16 October 2025

Biotechnology · Investment Trends · Mergers & Acquisitions · NASDAQ:OMER · NYSE:NVO · Pharma News · Stock Market

First Horizon (FHN) Stock Shocker: CEO’s Merger Hint Sends Shares Tumbling 13%

Stock Performance and Recent Trend According to market reports, FHN shares traded around $20 on Oct 15, 2025 after the selloff bloomberg.com. This was down ~13% from Wednesday’s open near $23.02 marketbeat.com. (FHN had just hit its 52-week high ~$23.63

16 October 2025

Company Analysis · Finance News · Investing · Mergers & Acquisitions · NYSE:FHN · Stock Market

Shocking Surge: Hillenbrand Stock Soars 19% on $32 Buyout Announcement

Lone Star Buyout Details Hillenbrand (NYSE: HI) announced on Oct. 15 that it will be acquired by Lone Star Funds in an all-cash deal at $32.00 per share ir.hillenbrand.com. At this price, the transaction’s enterprise value is roughly $3.8 billion, including Hillenbrand’s

15 October 2025

Business Updates · Financial Analysis · Investment News · Mergers & Acquisitions · NYSE:HI · Stock Market

Omeros Stock Explodes 146% on Surprise $2.1B Novo Nordisk Deal – What Comes Next?

Novo Nordisk Licensing Deal Sparks Rally On Oct. 15, Novo Nordisk (NYSE: NVO) and Omeros announced a landmark deal licensing zaltenibart (OMS906), Omeros’s experimental MASP-3 inhibitor for rare blood/kidney diseases investor.omeros.com. Under the agreement, Novo pays $340M upfront and can

15 October 2025

Financial Analysis · Investment News · Mergers & Acquisitions · NASDAQ:OMER · NYSE:NVO · Pharma Industry · Stock Market

Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

Deal Details: Novo Licenses Omeros’s MASP-3 Inhibitor On Oct. 15, Novo Nordisk and Seattle-based Omeros announced a definitive asset purchase and license agreement. Under the terms, Novo gains exclusive global rights to zaltenibart (OMS906) for all indications. Omeros will receive $340

15 October 2025

Biotech Industry · Business Analysis · Mergers & Acquisitions · NASDAQ:AKRO · NASDAQ:OMER · NYSE:NVO · Pharma News · Rare Diseases

Mergers & Acquisitions News 15 October 2025 - 18 October 2025